F2RL3 and Venous thrombosis: Despite all of these successful approaches, only very recently the utility of function-blocking anti-PAR4 antibodies have been used experimentally, and its experimental essay for targeting the thrombin cleavage site of PAR4 was highly specific and surprisingly efficacious when examined in similar platelet-based functional assays and in the in vitro human thrombosis model.